Complications and Discharge after Radical Cystectomy for Older Patients with Muscle-Invasive Bladder Cancer: The ELCAPA-27 Cohort Study.

complications discharge functional decline geriatric assessment length of hospital stay older patient radical cystectomy

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
29 Nov 2021
Historique:
received: 25 10 2021
revised: 16 11 2021
accepted: 25 11 2021
entrez: 10 12 2021
pubmed: 11 12 2021
medline: 11 12 2021
Statut: epublish

Résumé

Radical cystectomy is the standard of care for localized bladder cancer but is associated with high morbidity and mortality rates-especially among older patients with comorbidities. The association between geriatric assessment parameters on post-operative complications and discharge has not previously been investigated. The present analysis of the Elderly Cancer Patient (ELCAPA) prospective cohort included all patients aged ≥70 having undergone a geriatric assessment and then radical cystectomy for localized muscle-invasive bladder cancer between 2007 and 2018. The primary endpoint was the proportion of patients with one or more complications in the first 30 days after cystectomy. The secondary endpoints were the length of hospital stay (LOS), the 30-day mortality, and discharge rates. Sixty-two patients (median age: 81; range: 79-83.8) were included. The 30-day complication rate was 73%, and 49% of the patients had experienced a major complication, according to the Clavien-Dindo classification. The 30-day mortality rate was 4%. None of the geriatric, oncological, or laboratory parameters were significantly associated with the occurrence or severity of complications. The median (interquartile range) LOS was 18 days (15-23) overall and was longer in patients with complications (19 days vs. 15 days in those without complications;

Identifiants

pubmed: 34885120
pii: cancers13236010
doi: 10.3390/cancers13236010
pmc: PMC8656698
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Br J Cancer. 2013 Apr 16;108(7):1534-40
pubmed: 23481180
J Urol. 2018 Feb;199(2):543-550
pubmed: 28789948
BMC Urol. 2018 Oct 22;18(1):91
pubmed: 30348141
Prog Urol. 2019 Feb;29(2):63-75
pubmed: 30635149
J Urol. 2017 Nov;198(5):1039-1045
pubmed: 28533006
J Urol. 2021 Jan;205(1):94-99
pubmed: 32716672
J Urol. 2012 Jun;187(6):2011-7
pubmed: 22498229
JAMA Netw Open. 2020 Aug 3;3(8):e209265
pubmed: 32822490
Ann Surg Oncol. 2014 Dec;21(13):4383-9
pubmed: 25047468
Clin Genitourin Cancer. 2017 Aug;15(4):e615-e621
pubmed: 28139446
Eur Urol. 2018 Jan;73(1):40-50
pubmed: 28478043
J Clin Oncol. 2011 Sep 20;29(27):3636-42
pubmed: 21709194
J Urol. 2006 Dec;176(6 Pt 1):2612-7; discussion 2617-8
pubmed: 17085172
Urology. 2011 Mar;77(3):660-6
pubmed: 21256568
Eur Urol. 2009 Jan;55(1):164-74
pubmed: 18675501
J Clin Oncol. 2018 Aug 1;36(22):2326-2347
pubmed: 29782209
Urology. 2018 Nov;121:39-43
pubmed: 30076943
J Geriatr Oncol. 2020 Sep;11(7):1043-1053
pubmed: 32057720
Can J Urol. 2013 Aug;20(4):6826-31
pubmed: 23930606
J Urol. 2021 Feb;205(2):400-406
pubmed: 32897772
Eur Urol. 2021 Jan;79(1):82-104
pubmed: 32360052
Int Urol Nephrol. 2008;40(4):893-9
pubmed: 18317944
Ther Adv Urol. 2020 May 10;12:1756287220916614
pubmed: 32435276

Auteurs

Romain Geiss (R)

Department of Geriatrics, AP-HP, Hôpital Européen Georges Pompidou, 75015 Paris, France.

Lucrezia Sebaste (L)

Department of Geriatrics, AP-HP, Hôpital Européen Georges Pompidou, 75015 Paris, France.

Rémi Valter (R)

Department of Public Health, AP-HP, Hôpital Henri-Mondor, 94000 Créteil, France.

Johanne Poisson (J)

Department of Geriatrics, AP-HP, Hôpital Européen Georges Pompidou, 75015 Paris, France.
Center for Research on Inflammation, Université de Paris, Inserm U1149, 75018 Paris, France.

Soraya Mebarki (S)

Department of Geriatrics, AP-HP, Hôpital Européen Georges Pompidou, 75015 Paris, France.

Catherine Conti (C)

Department of Geriatrics, AP-HP, Hôpital Européen Georges Pompidou, 75015 Paris, France.

Dimitri Vordos (D)

Department of Urology, AP-HP, Hôpital Henri-Mondor, 94000 Créteil, France.

Michael Bringuier (M)

Department of Supportive Care and Medical Oncology, Institut Curie, 92210 Saint-Cloud, France.

Arnaud Méjean (A)

Department of Urology, AP-HP, Hôpital Européen Georges Pompidou, 75015 Paris, France.

Pierre Mongiat-Artus (P)

Department of Urology, AP-HP, Hôpital Saint Louis, 75010 Paris, France.

Tristan Cudennec (T)

Department of Geriatrics, AP-HP, Hôpital Ambroise-Paré, 92100 Boulogne-Billancourt, France.

Florence Canoui-Poitrine (F)

Department of Public Health, AP-HP, Hôpital Henri-Mondor, 94000 Créteil, France.
Université Paris-Est, Inserm, IMRB, 94000 Créteil, France.

Philippe Caillet (P)

Department of Geriatrics, AP-HP, Hôpital Européen Georges Pompidou, 75015 Paris, France.
Université Paris-Est, Inserm, IMRB, 94000 Créteil, France.

Elena Paillaud (E)

Department of Geriatrics, AP-HP, Hôpital Européen Georges Pompidou, 75015 Paris, France.
Université Paris-Est, Inserm, IMRB, 94000 Créteil, France.
Faculty of Health, Université de Paris, 75006 Paris, France.

Classifications MeSH